LOX is highly expressed in hypoxic breast cancer cells and related to the invasive and metastatic potential of breast cancer by modulating focal adhesion kinase (FAK) activity and cell-ECM adhesion [83]. This evidence concerns the gene PTK2 and breast carcinoma.